IZALTREO Trademark
Trademark Overview
On Wednesday, November 17, 2021, a trademark application was filed for IZALTREO with the United States Patent and Trademark Office. The USPTO has given the IZALTREO trademark a serial number of 97129201. The federal status of this trademark filing is REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED as of Thursday, November 21, 2024. This trademark is owned by Glaxo Group Limited. The IZALTREO trademark is filed in the Pharmaceutical Products category with the following description:
Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders
General Information
| Serial Number | 97129201 |
| Word Mark | IZALTREO |
| Filing Date | Wednesday, November 17, 2021 |
| Status | 654 - REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED |
| Status Date | Thursday, November 21, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, November 22, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Glaxo Group Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Brentford, Middlesex TW89GS |
Trademark Events
| Event Date | Event Description |
| Thursday, August 25, 2022 | ASSIGNED TO EXAMINER |
| Tuesday, August 30, 2022 | SUSPENSION LETTER WRITTEN |
| Tuesday, August 30, 2022 | LETTER OF SUSPENSION E-MAILED |
| Saturday, November 20, 2021 | NEW APPLICATION ENTERED |
| Monday, November 22, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, August 30, 2022 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Wednesday, November 9, 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Wednesday, November 9, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Thursday, November 21, 2024 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
| Saturday, May 24, 2025 | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION |
| Wednesday, November 9, 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Thursday, March 30, 2023 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
| Tuesday, October 17, 2023 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
| Wednesday, April 17, 2024 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
